Assessment of pre-specified adverse events following varicella vaccine: A population-based self-controlled risk interval study
- 8 February 2020
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 38 (11), 2495-2502
- https://doi.org/10.1016/j.vaccine.2020.01.090
Abstract
No abstract availableFunding Information
- Taiwan Ministry of Science and Technology (MOST 105-2314-B-002-055-MY2)
This publication has 37 references indexed in Scilit:
- The effect of influenza vaccination on risk of acute myocardial infarction: Self-controlled case-series studyVaccine, 2011
- Post‐varicella thrombocytopenic purpuraActa Paediatrica, 2010
- The decline of son preference and rise of gender indifference in Taiwan since 1990Demographic Research, 2009
- Varicella Vaccination and Ischemic Stroke in Children: Is There an Association?PEDIATRICS, 2009
- Risk of Immune Thrombocytopenic Purpura After Measles-Mumps-Rubella Immunization in ChildrenPEDIATRICS, 2008
- Safety of Varicella Vaccine after Licensure in the United States: Experience from Reports to the Vaccine Adverse Event Reporting System, 1995–2005The Journal of Infectious Diseases, 2008
- Four different study designs to evaluate vaccine safety were equally validated with contrasting limitationsJournal of Clinical Epidemiology, 2006
- A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX? in healthy children*1Vaccine, 2002
- Vaccination with measles, mumps and rubella vaccine and varicella vaccine: safety, tolerability, immunogenicity, persistence of antibody and duration of protection against varicella in healthy childrenThe Pediatric Infectious Disease Journal, 2002
- Live Attenuated Varicella Virus VaccineThe New England Journal of Medicine, 1984